SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis
Clinical trial NCT06772363 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06772363
- Sponsor
- Fuzhou General Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-09
- Primary completion
- 2026-06-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.